Kwayar COVID-19, mRNA (Pfizer-BioNTech)

Wadatacce

• Faɗa wa mai ba ka maganin alurar riga kafi game da duk yanayin lafiyar ka, gami da idan ka:

Pfizer-BioNTech cutar coronavirus 2019 (COVID-19) a halin yanzu ana nazarin allurar rigakafin rigakafin cutar coronavirus 2019 sanadiyyar cutar ta SARS-CoV-2. Babu wata rigakafin da FDA ta amince da ita don hana COVID-19.

Bayanai daga gwaji na asibiti ana samunsu a wannan lokacin don tallafawa amfani da allurar Pfizer-BioNTech COVID-19 don hana COVID-19. A cikin gwaji na asibiti, kimanin mutane 23,000 masu shekaru 12 zuwa sama sun karɓi aƙalla kashi 1 na alurar rigakafin Pfizer-BioNTech COVID-19. Ana buƙatar ƙarin bayani don sanin yadda alurar rigakafin Pfizer-BioNTech COVID-19 ke aiki don hana COVID-19 da yiwuwar afkuwar abubuwa daga gare ta.

Alurar rigakafin Pfizer-BioNTech COVID-19 ba ta sami daidaitaccen bita da FDA ta amince da shi ba don amfani. Koyaya, FDA ta amince da izinin Amfani da Gaggawa (EUA) don bawa manya da matasa shekaru 12 zuwa sama damar karɓar ta.

Yi magana da likitanka ko mai ba da allurar rigakafi game da haɗari da fa'idodi na karɓar wannan magani.

COVID-19 cuta ce ta kwayar kwayar cuta mai suna SARS-CoV-2. Wannan nau'in coronavirus din ba a taba ganin sa ba. Kuna iya samun COVID-19 ta hanyar tuntuɓar wani mutumin da ke da ƙwayar cutar. Yawanci cuta ce ta numfashi (huhu), amma kuma yana iya shafar wasu gabobin. Mutanen da ke da COVID-19 sun sami alamun bayyanar cututtuka da yawa da aka ruwaito, tun daga ƙananan alamun cuta zuwa cuta mai tsanani. Kwayar cutar na iya bayyana kwana 2 zuwa 14 bayan kamuwa da kwayar. Kwayar cutar na iya hadawa da: zazzabi, sanyi, tari, karancin numfashi, gajiya, jijiyoyi ko ciwon jiki, ciwon kai, rashin dandano ko wari, ciwon makogwaro, cunkoso, hanci, tashin zuciya, amai, ko gudawa.

Za a ba ku alurar rigakafin Pfizer-BioNTech COVID-19 a matsayin allurar cikin tsoka a cikin allurai 2, za a ba su makonni 3 dabam. Idan kun karɓi kashi ɗaya na maganin Pfizer-BioNTech COVID-19, ya kamata ku karɓi kashi na biyu na wannan daidai Alurar rigakafi makonni 3 daga baya don kammala jerin allurar rigakafin.

Faɗa wa mai ba ka maganin alurar riga kafi game da duk yanayin lafiyar ka, gami da idan ka:

• a sami wani rashin lafiyan.
• yi zazzabi
• suna da matsalar zubar jini ko shan jinin mai yauki kamar warfarin (Coumadin, Jantoven).
• samun rauni a garkuwar jiki ko kuma kana shan magani wanda ya shafi garkuwar jikinka.
• suna da ciki ko shirin yin ciki.
• suna nono.
• sun sami wani maganin rigakafin COVID-19.
• sun suma cikin haɗin allura
• sun sami mummunan rashin lafiyan bayan wani kashi na baya na wannan rigakafin.
• sun kamu da cutar rashin lafiyan duk wani sinadari a cikin wannan allurar.

A cikin gwajin gwaji da ke gudana, an nuna alurar rigakafin Pfizer-BioNTech COVID-19 don hana COVID-19 bayan samun allurai 2 da aka ba makonni 3 a baya. Yaya tsawon lokacin da kake kariya daga COVID-19 a halin yanzu ba a sani ba.

Hanyoyin da aka ruwaito tare da maganin Pfizer-BioNTech COVID-19 sun hada da:

• allurar ciwo, kumburi, da kuma ja
• gajiya
• ciwon kai
• ciwon tsoka
• jin sanyi
• ciwon gwiwa
• zazzaɓi
• tashin zuciya
• gudawa
• amai
• jin ba dadi
• kumburin kumburin lymph

Akwai yiwuwar nesa cewa alurar rigakafin Pfizer-BioNTech COVID-19 na iya haifar da mummunan tasirin rashin lafiyan. Ciwon rashin lafiyan zai iya faruwa yawanci tsakanin minutesan mintoci kaɗan bayan awa ɗaya bayan samun allurar Pfizer-BioNTech COVID-19.

Alamomin rashin lafiya mai tsanani na iya haɗawa da:

• wahalar numfashi
• kumburin fuskarka da makogwaro
• bugun zuciya mai sauri
• mummunan rash duk jikinka
• jiri da rauni

Waɗannan bazai zama dukkanin tasirin illa na rigakafin Pfizer-BioNTech COVID-19 ba. Abubuwa masu tsanani da ba zato ba tsammani na iya faruwa. Ana ci gaba da nazarin alurar rigakafin Pfizer-BioNTech COVID-19 a cikin gwajin asibiti.

• Idan ka gamu da wata matsala ta rashin lafiyan, kira 9-1-1, ko ka je asibiti mafi kusa.
• Kira mai ba da allurar rigakafin ko mai ba ku kiwon lafiya idan kuna da wata illa da ta dame ku ko ba ku tafi ba.
• Yi rahoton sakamako masu illa na rigakafi zuwa FDA / CDC Tsarin Rigakafin Bala'i na Bala'i (VAERS). Lambar kyauta ta VAERS ita ce 1-800-822-7967 ko yin rahoto kan layi zuwa https://vaers.hhs.gov/reportevent.html. Da fatan za a saka "Pfizer-BioNTech COVID-19 Vaccine EUA" a layin farko na akwatin # 18 na fom ɗin rahoton.
• Kari akan haka, zaku iya bayar da rahoton illar ga Pfizer Inc. a http://www.pfizersafetyreporting.com ko a 1-800-438-1985.
• Hakanan za'a iya ba ku zaɓi don yin rajista a cikin v-lafiya. V-safe shine sabon kayan aikin wayoyin hannu na son rai wanda ke amfani da saƙon rubutu da safiyoyin yanar gizo don bincika tare da mutanen da aka yiwa rigakafi don gano tasirin da ke tattare da cutar bayan rigakafin COVID-19. V-safe yayi tambayoyin da zasu taimaka CDC kula da lafiyar allurar rigakafin COVID-19. V-safe kuma yana ba da tuni na kashi biyu idan an buƙata kuma bin CDC ta wayar tarho idan mahalarta sun ba da rahoton mahimmancin tasirin kiwon lafiya bayan rigakafin COVID-19. Don ƙarin bayani kan yadda ake yin rajista, ziyarci: http://www.cdc.gov/vsafe.

A'a Alurar rigakafin Pfizer-BioNTech COVID-19 ba ta ƙunshi SARS-CoV-2 kuma ba za ta iya ba ku COVID-19 ba.

Lokacin da ka sami maganin ka na farko, zaka sami katin riga-kafi don nuna maka lokacin da zaka dawo don maganin ka na biyu na Pfizer-BioNTech COVID-19. Ka tuna ka kawo katin ka lokacin da ka dawo.

Mai ba da allurar rigakafin na iya haɗawa da bayanan alurar rigakafin ku a cikin tsarin ku na Jihohi / localaramar Hukumar Bayanin Rigakafin Rigakafi (IIS) ko wasu tsarin da aka tsara. Wannan zai tabbatar da cewa kun sami wannan maganin alurar riga kafi lokacin da kuka dawo don yin kashi na biyu. Don ƙarin bayani game da IISs ziyarci: https://www.cdc.gov/vaccines/programs/iis/about.html.

• Tambayi mai ba da allurar.
• Ziyarci CDC a https://www.cdc.gov/coronavirus/2019-ncov/index.html.
• Ziyarci FDA a http://bit.ly/3qI0njF.
• Tuntuɓi ma'aikatar kiwon lafiyar jama'a ta gida ko ta jihar.

A'a a wannan lokacin, mai bayarwa ba zai iya cajin ku da allurar rigakafi ba kuma ba za ku iya cajin kuɗin alurar rigakafi na aljihun kowane aljihu ko wani kuɗi ba idan kawai kuna karɓar rigakafin COVID-19. Koyaya, masu ba da allurar rigakafin na iya neman biyan da ya dace daga shirin ko shirin da ke rufe kuɗin gudanarwar rigakafin COVID-19 ga mai karɓar allurar (inshorar mai zaman kansa, Medicare, Medicaid, HRSA COVID-19 Uninsured Programme don waɗanda ba su da inshora).

Ana ƙarfafa mutanen da suka san duk wani abin da zai iya saɓa wa shirin na rigakafin CDC COVID-19 don a ba da rahoto ga Ofishin Sufeto Janar, Sashen Kiwon Lafiya na Amurka da Sabis na 'Yan Adam, a 1-800-HHS-TIPS ko TIPS.HHS. GOV.

Shirin Kula da Raunin Raunin Makamai (CICP) shiri ne na tarayya wanda zai iya taimakawa wajen biyan kuɗin kula da lafiya da sauran takamaiman kuɗin wasu mutane waɗanda wasu magunguna ko allurar rigakafi suka yi wa rauni, gami da wannan alurar. Gabaɗaya, dole ne a gabatar da da'awa ga CICP a cikin shekara ɗaya daga ranar karɓar alurar. Don ƙarin koyo game da wannan shirin, ziyarci http://www.hrsa.gov/cicp/ ko kira 1-855-266-2427.

Americanungiyar Amfani da ofwararrun Pharmwararrun Americanwararrun Americanwararrun Amurkawa, Inc. tana wakiltar cewa wannan bayanin game da allurar rigakafin Pfizer-BioNTech COVID-19 an tsara ta tare da daidaitaccen kulawa na kulawa, kuma daidai da ƙa'idodin ƙwarewa a fagen. An gargadi masu karatu cewa maganin Pfizer-BioNTech COVID-19 ba alurar rigakafi ce da aka yarda da ita ba game da cutar coronavirus 2019 (COVID-19) wanda SARS-CoV-2 ya haifar, amma dai, ana bincika kuma ana samin shi a halin yanzu a ƙarƙashin amfani da gaggawa na FDA izini (EUA) don hana COVID-19 a cikin manya da matasa shekaru 12 zuwa sama. Americanungiyar Magungunan Kiwon Lafiyar Jama'a ta Amurka, Inc. ba ta wakilci ko garanti, bayyana ko bayyana, gami da, amma ba'a iyakance ga, kowane garanti mai alamar ciniki da / ko dacewa don wata manufa ba, dangane da bayanin, kuma musamman ya watsar da duk irin wannan garanti. An sanar da masu karanta bayanai game da allurar rigakafin Pfizer-BioNTech COVID-19 cewa ASHP ba shi da alhakin ci gaba da kudin bayanan, ga duk wani kuskure ko rashi, da / ko kuma duk wani sakamakon da zai biyo bayan amfani da wannan bayanin. An shawarci masu karatu cewa yanke shawara game da maganin miyagun ƙwayoyi shawarwari ne masu rikitarwa na likita wanda ke buƙatar mai zaman kansa, yanke shawara na ƙwararren masanin kiwon lafiya, kuma ana ba da bayanin da ke cikin wannan bayanin don dalilai na bayani kawai. Americanungiyar Magungunan Magungunan Kiwan Lafiya ta Amurka, Inc. ba ta goyi bayan ko ba da shawarar amfani da kowane magani ba. Wannan bayanin game da allurar rigakafin Pfizer-BioNTech COVID-19 ba za a yi la'akari da shawarar mutum na haƙuri ba. Saboda yanayin canjin bayanan magungunan, an shawarce ka da ka tuntuɓi likitanka ko likitan magunguna game da takamaiman amfani da asibiti da kowane magani.

• BNT162b2 mRNA
• Comirnaty
• rigakafin mRNA COVID-19
• SARS-CoV-2 (COVID-19) alurar riga kafi, mRNA karuwar furotin
• Tozinameran